Skip to main content Accessibility help
×
Home

Symptomatic remission and neurocognitive functioning in patients with schizophrenia

  • A. Hofer (a1), T. Bodner (a2), A. Kaufmann (a1), G. Kemmler (a3), U. Mattarei (a1), N. M. Pfaffenberger (a3), M. A. Rettenbacher (a1), E. Trebo (a3), N. Yalcin (a1) and W. W. Fleischhacker (a1)...

Abstract

Background

A cross-sectional study was conducted in participants with schizophrenia to explore a potential association between the patients' remission status and neurocognitive functioning and to examine whether these factors have an impact on functional outcome.

Method

Psychopathological symptoms were rated by means of the Positive and Negative Syndrome Scale with symptom remission being assessed by applying the severity component of the recently proposed remission criteria. Tests for the cognitive battery were selected to cover domains known to be impaired in patients with schizophrenia. Next to pre-morbid intelligence, attention performance, executive functioning, verbal fluency, verbal learning and memory, working memory and visual memory were assessed. The joint effect of remission status and neurocognitive functioning on treatment outcome was investigated by logistic regression analysis.

Results

Out of 140 patients included in the study, 62 were symptomatically remitted. Mean age, education and sex distribution were comparable in remitted and non-remitted patients. Remitted patients showed significantly higher values on tests of verbal fluency, alertness and optical vigilance. Both symptomatic remission as well as performance on tests of working memory and verbal memory had a significant effect on the patients' employment status.

Conclusions

In the present study neuropsychological measures of frontal lobe functioning were associated with symptomatic remission from schizophrenia. In addition, both symptomatic remission and performance on tests of working memory and verbal memory had a significant effect on the patients' employment status. Longitudinal follow-up data are needed to determine how the associations of these determinants of functional outcome interact and change over time.

Copyright

Corresponding author

*Address for correspondence: A. Hofer, M.D., Medical University Innsbruck, Department of Psychiatry and Psychotherapy, Anichstrasse 35, A-6020 Innsbruck, Austria. (Email: alex.hofer@uki.at)

References

Hide All
Andreasen, NC, Carpenter, WT Jr., Kane, JM, Lasser, RA, Marder, SR, Weinberger, DR (2005). Remission in schizophrenia: proposed criteria and rationale for consensus. American Journal of Psychiatry 162, 441449.
Aschenberger, S, Tucher, O, Lange, KW (2000). Regensburger Wörtflüssigkeits-Test. Hogrefe Verlag für Psychologie: Göttingen.
Benton, AS, Spreen, O (1996). Der Benton Test. Handbuch: 7. Auflage. Huber: Bern.
Bond, GR, Drake, RE (2008). Predictors of competitive employment among patients with schizophrenia. Current Opinion in Psychiatry 21, 362369.
Bryson, G, Bell, MD (2003). Initial and final work performance in schizophrenia: cognitive and symptom predictors. Journal of Nervous and Mental Disease 191, 8792.
Buckley, PF, Harvey, PD, Bowie, CR, Loebel, A (2007). The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone. Schizophrenia Research 94, 99–106.
Catty, J, Lissouba, P, White, S, Becker, T, Drake, R, Fiorty, A, Knapp, M, Lauber, C, Rössler, W, Tomov, T, van Busschbach, J, Wiersma, D, Burns, T (2008). Predictors of employment for people with severe mental illness: results of an international six-centre randomised controlled trial. British Journal of Psychiatry 192, 224231.
Cervellione, KL, Burdick, KE, Cottone, JG, Rhinewine, JP, Kumra, S (2007). Neurocognitive deficits in adolescents with schizophrenia: longitudinal stability and predictive utility for short-term functional outcome. Journal of the American Academy of Child and Adolescent Psychiatry 46, 867878.
Ciudad, A, Álvarez, E, Bobes, J, San, L, Polavieja, P, Gilaberte, I (2009). Remission in schizophrenia: results from a 1-year follow-up observational study. Schizophrenia Research 108, 214222.
Davidson, M, Galderisi, S, Weiser, M, Werbeloff, N, Fleischhacker, WW, Keefe, RS, Boter, H, Keet, IP, Prelipceanu, D, Rybakowski, JK, Libiger, J, Hummer, M, Dollfus, S, López-Ibor, JJ, Hranov, LG, Gaebel, W, Peuskens, J, Lindefors, N, Riecher-Rössler, A, Kahn, RS (2009). Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). American Journal of Psychiatry 166, 675682.
Delis, DC, Kramer, JH, Kaplan, E, Ober, BA (1987). California Verbal Learning and Memory Test (Manual). Psychological Corporation: San Antonio, TX.
Fleischhacker, WW, Hummer, M, Hofer, A (2008). Schizophrene Störungen. In Handbuch der Psychopharmakotherapie(ed. Holsboer, F., Gründer, G. and Benkert, O.), pp. 847872. Springer-Verlag: Heidelberg.
Fujii, DE, Wylie, AM (2003). Neurocognition and community outcome in schizophrenia: long-term predictive validity. Schizophrenia Research 59, 219223.
Gold, JM, Goldberg, RW, McNary, SW, Dixon, LB, Lehman, AF (2002). Cognitive correlates of job tenure among patients with severe mental illness. American Journal of Psychiatry 159, 13951402.
Green, MF, Kern, RS, Braff, DL, Mintz, J (2000). Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”? Schizophrenia Bulletin 26, 119136.
Harvey, PD, Green, MF, Keefe, RSE, Velligan, DI (2004). Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness. Journal of Clinical Psychiatry 5, 361372.
Heaton, RK, Chelune, GJ, Taley, JL, Kay, GG, Curtiss, G (1993). Wisconsin Card Sorting Test Manual: Revised and Expanded. Psychological Assessment Resources: Odessa, FL.
Helldin, L, Kane, JM, Karilampi, U, Norlander, T, Archer, T (2006). Remission and cognitive ability in a cohort of patients with schizophrenia. Psychiatry Research 40, 738745.
Hofer, A, Baumgartner, S, Bodner, T, Edlinger, M, Hummer, M, Kemmler, G, Rettenbacher, MA, Fleischhacker, WW (2005). Patient outcomes in schizophrenia II: the impact of cognition. European Journal of Psychiatry 20, 395402.
Jarboe, KS, Schwartz, SK (1999). The relationship between medication noncompliance and cognitive function in patients with schizophrenia. Journal of the American Nurses' Association 5, S2S8.
Kaneda, Y, Jayathilak, H, Meltzer, H (2010). Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: cognitive impairment and clozapine treatment. Psychiatry Research 178, 5762.
Kay, SR, Fiszbein, A, Opler, LA (1987). The Positive and Negative Syndrome Scale for schizophrenia. Schizophrenia Bulletin 13, 261276.
Keefe, RS (2007). Cognitive deficits in patients with schizophrenia: effects and treatment. Journal of Clinical Psychiatry 68 (Suppl. 14), 8–13.
Keefe, RS, Bilder, RM, Davis, SM, Harvey, PD, Palmer, BW, Gold, JM, Meltzer, HY, Green, MF, Capuano, GT, Stroup, S, McEvoy, JP, Swartz, MS, Rosenheck, RA, Perkins, DO, Davis, CE, Hsiao, JK, Lieberman, JA; for the CATIE Investigators and the Neurocognitive Working Group (2007). Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Archives of General Psychiatry 64, 633647.
Keefe, RS, Bilder, RM, Harvey, PD, Davis, SM, Palmer, BW, Gold, JM, Meltzer, HY, Green, MF, Miller, DD, Canive, JM, Adler, LW, Manschreck, TC, Swartz, M, Rosenheck, R, Perkins, DO, Walker, TM, Stroup, TS, McEvoy, JP, Lieberman, JA (2006). Baseline neurocognitive deficits in the CATIE Schizophrenia Trial. Neuropsychopharmacology 31, 20332046.
Kern, RS, Green, MF, Satz, P (1992). Neuropsychological predictors of skills training for chronic psychiatric patients. Psychiatry Research 43, 223230.
Kopelowicz, A, Liberman, RP, Ventura, J, Zarate, R, Mintz, J (2005). Neurocognitive correlates of recovery from schizophrenia. Psychological Medicine 35, 11651173.
Lehrl, S (1977). Manual zum Mehrfachwahl-Wortschatz-Test-B (Multiple Choice Word Knowledge Test). Straube: Erlangen.
Leucht, S, Komossa, K, Rummel-Kluge, C, Corves, C, Hunger, H, Schmid, F, Asenjo Lobos, C, Schwarz, S, Davis, JM (2009). A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. American Journal of Psychiatry 166, 152163.
McClure, MM, Bowie, CR, Patterson, TL, Heaton, RK, Weaver, C, Anderson, H, Harvey, PD (2007). Correlations of functional capacity and neuropsychological performance in older patients with schizophrenia: evidence for specificity of relationships? Schizophrenia Research 89, 330338.
Nelson, HE (1992). National Adult Reading Test (NART). NFER-Nelson: Windsor, UK.
Norman, R, Malla, AK, Cortese, L, Cheng, S, Diaz, K, McIntosh, E, McLean, TS, Rickwood, A, Voruganti, LP (1999). Symptoms and cognition as predictors of community functioning: a prospective analysis. American Journal of Psychiatry 156, 400405.
Palmer, BW, Dawes, SE, Heaton, RK (2009). What do we know about neuropsychological aspects of schizophrenia? Neuropsychological Review 19, 365384.
Rempfer, MV, Hamera, EK, Brown, CE, Cromwell, RL (2003). The relations between cognition and the independent living skill of shopping in people with schizophrenia. Psychiatry Research 117, 103112.
van Os, J, Burns, T, Cavallaro, R, Leucht, S, Peuskens, J, Helldin, L, Bernardo, M, Arango, C, Fleischhacker, WW, Lachaux, B, Kane, JM (2006). Standardized remission criteria in schizophrenia. Acta Psychiatrica Scandinavica 113, 9195.
Velligan, DI, Bow-Thomas, CC, Mahurin, RK, Miller, AL, Halgunseth, LC (2000). Do specific neurocognitive deficits predict specific domains of community function in schizophrenia? Journal of Nervous and Mental Disease 188, 518524.
Velligan, DI, Mahurin, RK, Diamond, PL, Hazleton, BC, Eckert, SL, Miller, AL (1997). The functional significance of symptomatology and cognitive function in schizophrenia. Schizophrenia Research 25, 2131.
Wegener, S, Redoblado-Hodge, MA, Lucas, S, Fitzgerald, D, Harris, A, Brennan, J (2005). Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. Australian and New Zealand Journal of Psychiatry 39, 487492.
Williams, LM, Withford, TJ, Flynn, G, Wong, W, Liddell, BJ, Silverstein, S, Galletly, C, Harris, AW, Gordon, E (2008). General and social cognition in first episode schizophrenia: identification if separable factors and prediction of functional outcome using the IntegNeuro test battery. Schizophrenia Research 99, 182191.
Zanello, A, Perrig, L, Huguelet, P (2006). Cognitive functions related to interpersonal problem-solving skills in schizophrenic patients compared with healthy subjects. Psychiatry Research 142, 6778.
Zimmermann, P, Fimm, B (2002). Testbatterie zur Aufmerksamkeitsprüfung,Version 1.7 (Test Battery of Attentional Performance). Vera Fimm/Psychologische Testsysteme: Herzogenrath.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed